Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1R3C

THE STRUCTURE OF P38ALPHA C162S MUTANT

1R3C の概要
エントリーDOI10.2210/pdb1r3c/pdb
関連するPDBエントリー1R39
分子名称Mitogen-activated protein kinase 14, MAGNESIUM ION (3 entities in total)
機能のキーワードserine/threonine kinase, mutagenesis, stabilization, transferase
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm : Q16539
タンパク質・核酸の鎖数1
化学式量合計42031.48
構造登録者
Patel, S.B.,Cameron, P.M.,Frantz-Wattley, B.,O'Neill, E.,Becker, J.W.,Scapin, G. (登録日: 2003-10-01, 公開日: 2004-01-20, 最終更新日: 2023-08-23)
主引用文献Patel, S.B.,Cameron, P.M.,Frantz-Wattley, B.,O'Neill, E.,Becker, J.W.,Scapin, G.
Lattice stabilization and enhanced diffraction in human p38 alpha crystals by protein engineering.
Biochim.Biophys.Acta, 1696:67-73, 2004
Cited by
PubMed Abstract: Mitogen-activated protein (MAP) kinase p38 alpha is activated in response to environmental stress and cytokines, and plays a significant role in inflammatory responses. For these reasons, it is an important target for the treatment of a wide range of inflammatory and autoimmune diseases. The crystals of p38 alpha that we obtained by published procedures were usually small, quite mosaic, and difficult to reproduce and thus posed a difficulty for the intensive high-resolution studies required for a structure-guided drug discovery approach. Based on crystallographic and biochemical evidences, we prepared a single point mutation of a surface cysteine (C162S) and found that it prevents aggregation and improves the homogeneity and stability of the enzyme. This mutation also facilitates the crystallization process and increases the diffracting power of p38 alpha crystals. Surprisingly, we found that the mutation induces a change in the conformation of a nearby surface loop resulting in stronger lattice interactions, consistent with the improved crystal quality. The mutant protein, because of its improved stability and strengthened lattice interactions, thus provides a significantly improved reagent for use in structure-based drug design for this important disease target.
PubMed: 14726206
DOI: 10.1016/j.bbapap.2003.09.009
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2 Å)
構造検証レポート
Validation report summary of 1r3c
検証レポート(詳細版)ダウンロードをダウンロード

237735

件を2025-06-18に公開中

PDB statisticsPDBj update infoContact PDBjnumon